234 related articles for article (PubMed ID: 28483551)
21. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
22. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus.
Pinkenburg O; Meyer T; Bannert N; Norley S; Bolte K; Czudai-Matwich V; Herold S; Gessner A; Schnare M
PLoS One; 2016; 11(6):e0156929. PubMed ID: 27273104
[TBL] [Abstract][Full Text] [Related]
23. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
[TBL] [Abstract][Full Text] [Related]
24. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
25. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
Haidari M; Ali M; Ward Casscells S; Madjid M
Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
[TBL] [Abstract][Full Text] [Related]
26. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
27. Antiviral Activity of Peanut (Arachis hypogaea L.) Skin Extract Against Human Influenza Viruses.
Makau JN; Watanabe K; Mohammed MMD; Nishida N
J Med Food; 2018 Aug; 21(8):777-784. PubMed ID: 29847745
[TBL] [Abstract][Full Text] [Related]
28. Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
Vanderlinden E; Vanstreels E; Boons E; ter Veer W; Huckriede A; Daelemans D; Van Lommel A; Rőth E; Sztaricskai F; Herczegh P; Naesens L
J Virol; 2012 Sep; 86(17):9416-31. PubMed ID: 22740402
[TBL] [Abstract][Full Text] [Related]
29. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo.
Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z
Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588
[TBL] [Abstract][Full Text] [Related]
30. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
31. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
33. Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth.
Li C; Xu LJ; Lian WW; Pang XC; Jia H; Liu AL; Du GH
Acta Pharmacol Sin; 2018 Dec; 39(12):1913-1922. PubMed ID: 29802302
[TBL] [Abstract][Full Text] [Related]
34. Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection- In vitro and in silico biochemical and toxicological screening.
Nile SH; Kim DH; Nile A; Park GS; Gansukh E; Kai G
Food Chem Toxicol; 2020 Jan; 135():110985. PubMed ID: 31765700
[TBL] [Abstract][Full Text] [Related]
35. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
[TBL] [Abstract][Full Text] [Related]
36. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses.
Zhang J; Hu Y; Hau R; Musharrafieh R; Ma C; Zhou X; Chen Y; Wang J
Eur J Pharm Sci; 2019 May; 133():86-94. PubMed ID: 30930289
[TBL] [Abstract][Full Text] [Related]
37. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
[No Abstract] [Full Text] [Related]
39. Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.
Song EJ; Españo E; Shim SM; Nam JH; Kim J; Lee K; Park SK; Lee CK; Kim JK
Sci Rep; 2021 May; 11(1):9427. PubMed ID: 33941825
[TBL] [Abstract][Full Text] [Related]
40. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
